Last reviewed · How we verify

NCT07228065

Fixed-Dose Combinations Pragmatic Randomized Implementation Trial for Blood Pressure Control

Not yet recruiting NA Last updated 27 March 2026
What this trial tests

NA trial testing Provider nudge in Hypertension in 720 participants. Not yet recruiting.

Timeline
1 May 2026
Primary endpoint
31 March 2027
31 May 2027

Quick facts

Lead sponsorBrigham and Women's Hospital
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment720
Start date1 May 2026
Primary completion31 March 2027
Estimated completion31 May 2027

Drugs / interventions tested

Conditions studied

Sponsor

Brigham and Women's Hospital

Who can join

Adults 18 to 80, any sex, with Hypertension or Primary Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed study is an effectiveness-implementation hybrid type II trial designed to evaluate the impact of provider- and patient-directed interventions on FDC use. The trial will test the effectiveness of theory-driven nudges tailored to address provider and patient barriers. All interventions will be pharmacist-driven, with pharmacists delivering information via nudges to providers and via nudges or more intensive interventions (i.e., CPA) to patients. Data to evaluate outcomes will be extracted from electronic health records.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Provider nudge

Trials testing the same drug.

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other Brigham and Women's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07228065.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing